使用含光裂合酶的医疗器械对癌化区域进行管理：一项随机、双盲、平行组的试点研究。 - Suppr

Suppr

超能文献

Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study.

作者信息

Moscarella E, Argenziano G, Longo C, Aladren S

机构信息

Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy.

Dermatology Unit, Second University of Naples, Naples, Italy.

出版信息

J Eur Acad Dermatol Venereol. 2017 Sep;31(9):e401-e403. doi: 10.1111/jdv.14209. Epub 2017 Mar 29.

DOI:10.1111/jdv.14209

PMID:28294419

Abstract

摘要

相似文献

Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study.使用含光裂合酶的医疗器械对癌化区域进行管理：一项随机、双盲、平行组的试点研究。

J Eur Acad Dermatol Venereol. 2017 Sep;31(9):e401-e403. doi: 10.1111/jdv.14209. Epub 2017 Mar 29.

Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.基于光解酶的设备在治疗光化性角化病和非黑素瘤皮肤癌患者癌前病变中的疗效。

G Ital Dermatol Venereol. 2013 Dec;148(6):693-8.

Comparative Effects of Sunscreens Alone vs Sunscreens Plus DNA Repair Enzymes in Patients With Actinic Keratosis: Clinical and Molecular Findings from a 6-Month, Randomized, Clinical Study.单独使用防晒霜与防晒霜加DNA修复酶对光化性角化病患者的比较效果：一项为期6个月的随机临床研究的临床和分子结果

J Drugs Dermatol. 2015 Sep;14(9):986-90.

The use of a sunscreen containing DNA-photolyase in the treatment of patients with field cancerization and multiple actinic keratoses: a case-series.含DNA光解酶的防晒霜在治疗场癌化和多发性光化性角化病患者中的应用：病例系列

Dermatol Online J. 2017 Jan 15;23(1):13030/qt5zc6085s.

A 9-month, randomized, assessor-blinded, parallel-group study to evaluate clinical effects of film-forming medical devices containing photolyase and sun filters in the treatment of field cancerization compared with sunscreen in patients after successful photodynamic therapy for actinic keratosis.一项为期9个月的随机、评估者盲法、平行组研究，旨在评估含光解酶和成膜防晒剂的医疗器械在光动力疗法成功治疗光化性角化病的患者中，与防晒霜相比，对场癌化治疗的临床效果。

Br J Dermatol. 2016 Dec;175(6):1391-1393. doi: 10.1111/bjd.14721. Epub 2016 Oct 18.

Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial.光解酶防晒霜或常规防晒霜联合局部抗氧化剂治疗晚期光损伤和皮肤原位癌的疗效：一项随机临床试验。

An Bras Dermatol. 2022 Mar-Apr;97(2):157-165. doi: 10.1016/j.abd.2021.06.005. Epub 2022 Jan 14.

Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.一种含有防晒霜（防晒指数50+）和0.8%吡罗昔康的成膜医疗设备治疗光化性角化病和场癌化的疗效：一项多中心、评估者盲法的3个月试验。

Curr Med Res Opin. 2017 Jul;33(7):1255-1259. doi: 10.1080/03007995.2017.1313212. Epub 2017 Apr 20.

A Novel Technology: Sunscreen With Actinic Damage Repair.一项新技术：具有光化性损伤修复功能的防晒霜。

J Drugs Dermatol. 2017 May 1;16(5):s59-s60.

Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis.使用含0.8%吡罗昔康和防晒系数为50+防晒霜的医疗设备治疗光化性角化病的场癌化的荧光光诊断评估。

Photodermatol Photoimmunol Photomed. 2019 Jul;35(4):277-279. doi: 10.1111/phpp.12452. Epub 2019 Feb 18.

The efficacy of a photolyase-based device on the cancerization field: a clinical and thermographic study.一种基于光裂合酶的设备对癌化区域的疗效：一项临床和热成像研究。

J Exp Clin Cancer Res. 2015 Aug 19;34(1):84. doi: 10.1186/s13046-015-0203-0.

引用本文的文献

Effect of a Photolyase-Based Medical Device on Actinic Keratosis in Phototypes III-IV Patients: Real-Life Clinical Setting.一种基于光裂合酶的医疗设备对Ⅲ-Ⅳ型光皮肤患者光化性角化病的影响：真实临床环境

Dermatol Ther (Heidelb). 2025 Jun 16. doi: 10.1007/s13555-025-01455-6.

Understanding Active Photoprotection: DNA-Repair Enzymes and Antioxidants.了解主动光防护：DNA修复酶与抗氧化剂

Life (Basel). 2024 Jun 28;14(7):822. doi: 10.3390/life14070822.

Short-Term UVB Irradiation Leads to Persistent DNA Damage in Limbal Epithelial Stem Cells, Partially Reversed by DNA Repairing Enzymes.短期紫外线B照射导致角膜缘上皮干细胞持续性DNA损伤，DNA修复酶可部分逆转该损伤。

Biology (Basel). 2023 Feb 7;12(2):265. doi: 10.3390/biology12020265.

AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients.AKASI和近红外光谱在免疫功能正常和免疫功能低下患者中对一种光化性角化病预防产品的联合有效性评估

Front Med (Lausanne). 2022 Sep 7;9:987696. doi: 10.3389/fmed.2022.987696. eCollection 2022.

Photolyase Production and Current Applications: A Review.光解酶的生产及应用综述。

Molecules. 2022 Sep 15;27(18):5998. doi: 10.3390/molecules27185998.

UV Protection in the Cornea: Failure and Rescue.角膜中的紫外线防护：失效与补救

Biology (Basel). 2022 Feb 10;11(2):278. doi: 10.3390/biology11020278.

An Bras Dermatol. 2022 Mar-Apr;97(2):157-165. doi: 10.1016/j.abd.2021.06.005. Epub 2022 Jan 14.

Six critical questions for DNA repair enzymes in skincare products: a review in dialog.护肤产品中DNA修复酶的六个关键问题：对话式综述

Clin Cosmet Investig Dermatol. 2019 Aug 29;12:617-624. doi: 10.2147/CCID.S220741. eCollection 2019.

Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis.含光裂解酶的成膜医疗器械在光化性角化病场癌化管理中防治的10年临床证据综述

Dermatol Ther (Heidelb). 2019 Jun;9(2):259-270. doi: 10.1007/s13555-019-0294-1. Epub 2019 Apr 9.

New Vision in Photoprotection and Photorepair.光保护与光修复的新视野。

Dermatol Ther (Heidelb). 2019 Mar;9(1):103-115. doi: 10.1007/s13555-019-0282-5. Epub 2019 Jan 23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验